Widely used:Recently Viewed
Clear All$4.33
$-0.11
(-2.46%)
As on 25-Apr-2025 16:00EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$----
P/E Ratio
--
P/B Ratio
0
Industry P/E
--
Debt to Equity
--
ROE
0 %
ROCE
31.77 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
S$--
EBITDA
S$--
Net Profit
S$--
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
| -- | 3.59 | -- | -- | -- | -- | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Basel Medical Group Ltd engages in the provision of healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports... medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions. The company was incorporated in 2023 and is based in Singapore. Address: 600 North Bridge Road, Singapore, Singapore, 188778 Read more
Group CEO & Director
Mr. Wai Man Cheung
Group CFO & Director
Ms. Jianing Lu
Headquarters
Singapore
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Basel Medical Group Ltd Ordinary Shares (BMGL) is $4.33 (NASDAQ) as of 25-Apr-2025 16:00 EDT. Basel Medical Group Ltd Ordinary Shares (BMGL) has given a return of --% in the last 1 years.
Basel Medical Group Ltd Ordinary Shares (BMGL) has a market capitalisation of -- as on 24-Apr-2025. As per Value Research classification, it is a company.
Since, TTM earnings of Basel Medical Group Ltd Ordinary Shares (BMGL) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Basel Medical Group Ltd Ordinary Shares (BMGL) and enter the required number of quantities and click on buy to purchase the shares of Basel Medical Group Ltd Ordinary Shares (BMGL).
Basel Medical Group Ltd engages in the provision of healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions. The company was incorporated in 2023 and is based in Singapore. Address: 600 North Bridge Road, Singapore, Singapore, 188778
The CEO & director of Mr. Wai Man Cheung. is Basel Medical Group Ltd Ordinary Shares (BMGL), and CFO & Sr. VP is Ms. Jianing Lu.
There is no promoter pledging in Basel Medical Group Ltd Ordinary Shares (BMGL).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | Ratios |
|---|---|
|
Return on equity(%)
|
31.77
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
20.62
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Basel Medical Group Ltd Ordinary Shares (BMGL) was No Profit.
